The data revealed that patients with PC and positive expression of cyclin D1 had a shorter disease-free survival (28.5 months) compared to those who did not express cyclin D1 (67.6 months), although the difference was not statistically significant (log-rank p = 0.669) (Figure 2). Here, CCND1 is linked to pachyonychia congenita.